In the pharmaceutical industry, the salary scale is a key issue for ensuring fair compensation based on responsibilities, seniority, and skills. Collective bargaining agreement 3097, which notably concerns industry giants such as Sanofi, Roche, Pfizer, and Novartis, provides a precise structure to regulate employee compensation at all levels. In 2025, this scale will evolve to reflect both salary demands and the economic impact of transformations in the sector. Salary management must therefore adapt to the specificities of each group, from entry-level to senior management, while maintaining a certain flexibility in the face of industry demands. Understanding the mechanisms, classifications, and issues related to this scale is becoming essential for HR managers, but also for employees themselves, who must be aware of their rights and opportunities for advancement. This framework, essential to job stability, remains a strategic lever for major players like GSK and Servier, and helps make the pharmaceutical industry an attractive sector despite fierce competition and cost pressures.

The fundamentals of the salary scale in the 3097 agreement for the pharmaceutical industry

To understand the salary landscape in the pharmaceutical industry in 2025, it is imperative to analyze the segmentation into groups and classification levels. Collective bargaining agreement 3097 distinguishes a wide variety of positions, ranging from the simplest to the most technically demanding, with compensation tailored to each category. The regularly updated classification aims to guarantee a minimum wage for all while promoting employees’ career advancement. The salary scale is the cornerstone of this economic structure, aimed at ensuring fairness and motivation within companies such as Ipsen, Boehringer Ingelheim, and Merck. Its scraping/lart-de-la-data-a-votre-portee-comment-le-web-scraping-peut-transformer-votre-entreprise/">application also helps establish the basis for annual negotiations, particularly during collective or individual raises. Precise knowledge of thresholds, classifications, and update procedures is a strategic issue for all stakeholders in a strict regulatory environment and under constant pressure from the global market.

Discover our salary scale, an essential tool for understanding compensation levels in your sector. Access up-to-date information to help you negotiate your salary and plan your career.

The Different Classification Groups and Their Compensation

The salary scale is divided into 11 groups, each of which reflects specific experience, responsibility, or technical skill levels. Here is a summary of the main groups:

  • Group 1A to 1C/2A: Entry-level or unskilled employees, paid around €1,534 to €1,567 gross monthly.
  • Group 2B to 3A: Employees with intermediate experience, earning between €1,600 and €1,674.
  • Group 3B to 4A: Skilled employees, often responsible for complex tasks, with salaries ranging from €1,714 to €1,862.
  • Group 4B to 5C/6A: Increased responsibilities, particularly in project management or supervision, with salaries of up to €2,450.
  • Groups 7A to 9B: Senior or specialized positions, earning between €2,981 and €5,065 net.
  • Groups 10 and 11: Senior managers and executives, with salaries exceeding €5,500, particularly at some large groups such as Servier and GSK. Band
Gross minimum wage (in €) 1A
1,534.64 1B
1,550.98 1C/2A
1,567.33 2B
1,600.02 2C/3A
1,673.57 3B
1,714.44 3C/4A
1,861.55 4B
1,926.93 4C/5A
2,114.90 5B
2,204.81 5C/6A
2,449.99 6B
2,564.41 6C
2,866.80 7A
2,981.22 7B
3,496.11 8A
3,610.53 8B
4,223.49 9A
4 337.91 9B
5,065.29 10
5,522.97 11
5,980.64 Salary Advancement and Negotiation Procedures Under Agreement 3097
→ À lire aussi Salary scale for agreement 3155 – Furniture (manufacturing) – Kevin Grillot Uncategorized · 12 Jul 2025

One of the major challenges remains the ability for an employee to advance within the salary scale based on their experience, skills, and increased responsibilities. The agreement provides specific mechanisms allowing employers like Roche or Merck to adjust compensation during annual negotiations. Salary increases can result from a simple negotiated raise or a promotion in classification. These processes are regulated to ensure transparency and fairness. The frequency of these adjustments is generally annual, but can also be part of a skills assessment or the implementation of a professional project. The implementation of these rules guarantees employees recognition of their career paths and their motivation to contribute to the success of leaders like Boehringer Ingelheim or Bristol-Myers Squibb. Discover our detailed salary scale, which will help you understand the differences in compensation across positions and sectors. Access detailed information to better negotiate your salary and plan your career.

Career development options and their impacts

Progress in classification often involves a significant salary increase, but also recognition of skills valued in research and development or manufacturing. The reform of the sector, particularly with the integration of new technologies and pharmacovigilance, favors the emergence of positions of responsibility, which play a key role in the competitiveness of large groups. For example, at GSK, biotechnology specialists can advance to higher levels within a few years, depending on their experience and contribution. Mastery of regulatory processes or quality certification can accelerate this progress.

The transparency of career paths, combined with continuing training tools, limits stagnation and promotes loyalty. The implementation of career plans and collective negotiations also allows large companies to adapt their salary scales while respecting the competitiveness of the international market.

Type of evolution
Salary impact

Annual increase From 2 to 4% on average, depending on performance
Classification progress Progression from 1 to 3 groups depending on new responsibilities
Training and certification Increase or specific bonus, depending on skills acquired
Internal mobility Taking on new missions, often accompanied by a revaluation
The challenges of transparency and fairness in salary setting An essential point in managing the salary scale is transparency, which guarantees fair recognition for all. Convention 3097 stipulates that the establishment of precise criteria for setting remuneration must ensure fairness. Among these criteria, we find seniority, technical expertise, level of responsibility, but also contribution to research or production. Transparency must also be accompanied by easy access to information, allowing employees to understand their potential development. Collective bargaining plays a major role in defining the terms, particularly at Servier or GSK, where unions actively participate in these discussions. Clear communication helps strengthen team motivation and loyalty, essential conditions for facing the challenges of the digital revolution and new regulatory regulations.
Salary scale for agreement 3321 – Rural family assistants (ADMR) – Kevin Grillot
→ À lire aussi Salary scale for agreement 3321 – Rural family assistants (ADMR) – Kevin Grillot Uncategorized · 10 Jul 2025

discover our complete salary scale which helps you understand the different salary scales in your sector. get clear information on salaries, benefits and comparisons, to better negotiate your salary and know your value in the market.

Equality and non-discrimination mechanisms

Ensuring equal pay in the pharmaceutical industry relies on robust mechanisms designed to prevent any form of discrimination. Implementing specific policies, including consideration of gender, origin, and age, is a crucial issue. Legislation requires companies like Pfizer and Novo Nordisk to conduct regular audits to identify and correct any disparities. Transparency in salary setting also requires standardized pay scales, which must adhere to principles of fairness. Raising manager awareness and providing ongoing training on these issues are essential to avoid any bias in skills assessment or compensation. Ultimately, a non-discriminatory salary policy is more than a legal obligation; it is also a prerequisite for strengthening social cohesion and corporate social responsibility in the sector. Criteria

Recommended Action

Regular Salary Audit

Identify and Correct Disparities Manager Training
Raise Awareness of Equality and Non-Discrimination Establish Transparent Salary Scales
Ensure Fairness and Consistency Integration Policy
Promote Diversity by Recruiting and Promoting Equitably Challenges Related to Employee Revaluation in the Pharmaceutical Industry
The increasingly competitive environment requires companies like Roche and Bristol-Myers Squibb to constantly reposition their salary strategies. Revaluations must take into account economic growth, inflation, as well as risks related to intellectual property and regulatory changes. Collective bargaining is a key step in ensuring competitive compensation that meets employee expectations and the company’s challenges. Implementing a flexible salary scale helps retain talent and recognizes experience gained in constantly evolving sectors. Transparency in these processes is becoming a motivating and engaging factor for all teams, particularly in large groups like Ipsen and Servier, where innovation remains the main driver. The pressure to balance competitiveness and social cohesion is also leading to a rethinking of salary scale flexibility, in line with the growth of the biotechnology sector and the rise of personalized medicine. Strategies for maintaining salary competitiveness

To remain competitive, particularly in a market as dynamic as biotech, companies must develop effective compensation strategies. This includes aligning salary policies with performance and the added value provided. Implementing performance bonuses, group bonuses, or benefits in kind is often an effective response. A flexible salary scale, which can adapt to industry developments or foreign markets, is another essential lever. At Bristol-Myers Squibb and GSK, these innovative approaches help promote skills while ensuring the company’s financial stability. Furthermore, it is advisable to incorporate regular employee discussion mechanisms to anticipate and adjust compensation based on economic or regulatory fluctuations. Transparency and consultation remain the pillars of a balanced salary policy, whether it concerns the pharmacovigilance sector or oncology research. Strategy

Impact

Bonuses and Bonuses

Strengthening Motivation and Loyalty

Flexibility of the Scale Adapting to Sector Changes
Regular Discussions Anticipating Necessary Adjustments
Increased Transparency Strengthening Trust and Commitment
FAQ on the Salary Scale in Agreement 3097 for the Pharmaceutical Industry What is the difference between a Level 1A employee and a Level 11 manager?
A Level 1A employee receives a gross salary of approximately €1,534, while a Level 11 manager can earn more than €5,980, reflecting increased responsibilities and specialized expertise. How will the salary scale evolve in 2025 compared to 2024?
Salary scale for agreement 3066 – Florists – Kevin Grillot
→ À lire aussi Salary scale for agreement 3066 – Florists – Kevin Grillot Uncategorized · 02 Aug 2025

The salary increase policy is part of a dynamic of adjusting to inflation, promoting skills, and consolidating the sector in the face of international competition. Revaluations can reach 3 to 4% on average, depending on performance and collective bargaining.

  1. What are the ways for an employee to access a higher position in this sector? Advancement involves continuing education, taking on leadership roles, skills certification, and negotiation during annual reviews, particularly at companies like Novartis or Merck.
  2. Is the salary scale compatible with European regulations? Yes, it is aligned with EU directives, particularly regarding equality and non-discrimination, while allowing for local adaptation according to national specificities.

📋 Checklist SEO gratuite — 50 points à vérifier

Téléchargez ma checklist SEO complète : technique, contenu, netlinking. Le même outil que j'utilise pour mes clients.

Télécharger la checklist

Besoin de visibilité pour votre activité ?

Je suis Kevin Grillot, consultant SEO freelance certifié. J'accompagne les TPE et PME en référencement naturel, Google Ads, Meta Ads et création de site internet.

Kevin Grillot

Écrit par

Kevin Grillot

Consultant Webmarketing & Expert SEO.

Voir tous les articles →
Ressource gratuite

Checklist SEO Local gratuite — 15 points à vérifier

Téléchargez notre checklist et vérifiez si votre site est optimisé pour Google.

  • 15 points essentiels pour le SEO local
  • Format actionnable et imprimable
  • Utilisé par +200 entrepreneurs

Vos données restent confidentielles. Aucun spam.